Qube Research & Technologies (QRT)’s CureVac CVAC Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,712,737	Closed	-$9.23M	–	3736
2025 Q3	$9.23M	Buy	1,712,737 +530,686	+45%	+$2.87M	0.01%	1382
2025 Q2	$6.42M	Buy	+1,182,051	New	+$4.69M	0.01%	1560
2023 Q1	–	Sell	-13,542	Closed	-$81.7K	–	2614
2022 Q4	$81.7K	Sell	13,542 -12,506	-48%	-$92.4K	﹤0.01%	2045
2022 Q3	$205K	Sell	26,048 -48,163	-65%	-$562K	﹤0.01%	1766
2022 Q2	$1.01M	Buy	+74,211	New	+$1.23M	0.01%	1099
2021 Q1	–	Sell	-3,519	Closed	-$285K	–	1990
2020 Q4	$285K	Buy	+3,519	New	+$269K	﹤0.01%	1377

Other funds holding CVAC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CVAC Position: Q4 2025 in Review

Qube Research & Technologies (QRT) sold out of CureVac (CVAC) in Q4 2025, closing a stake of 1,712,737 shares — an estimated $9.23M sold.

Qube Research & Technologies (QRT) first reported a position in CVAC in Q4 2020 and held it in 6 quarters. The position peaked at $9.23M in Q3 2025. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

Qube Research & Technologies (QRT) reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 1,712,737 CureVac shares in Q4 2025, an estimated $9.23M.
Qube Research & Technologies (QRT) first reported a position in CureVac in Q4 2020 and held it in 6 quarters.
Qube Research & Technologies (QRT)'s CureVac position peaked at $9.23M in Q3 2025.
57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.